Pulsatile Stretch Induces Release of Angiotensin II and Oxidative Stress in Human Endothelial Cells: Effects of ACE Inhibition and AT₁ Receptor Antagonism

References

• Wever RMF, Lüscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998; 97: 108–112
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005; 25: 29–38
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006; 71: 247–258
   PubMed Web of Science ®Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res. 2000; 86: 494–501
   PubMed Web of Science ®Google Scholar
• Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens. 2004; 22: 35–542
   PubMed Web of Science ®Google Scholar
• Chalupsky K, Cai H. Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2005; 102: 9056–9061
   PubMed Web of Science ®Google Scholar
• Pitt B. ACE inhibitors for patients with vascular disease without left ventricular dysfunction—may they rest in PEACE?. N Engl J Med. 2004; 351: 2115–2117
   PubMed Web of Science ®Google Scholar
• Mancia G, Weber M. A new dawn in cardiovascular protection: Blood pressure lowering through AT1 blockade. J Hypertens. 2003; 21(Suppl. 6)S1–S2
   PubMedGoogle Scholar
• Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Wachawin MA, et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in athersclerosis. Circulation. 2000; 101: 2349–2354
   PubMed Web of Science ®Google Scholar
• Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, et al. Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease. Role of superoxide dismutase. Circulation. 2001; 103: 799–805
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003; 41: 1281–1286
   PubMed Web of Science ®Google Scholar
• Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishikawa N, Nishio M, et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension. 2004; 43: 686–691
   PubMed Web of Science ®Google Scholar
• Lehoux S. Redox signalling in vascular responses to shear and stretch. Cardiovasc Res. 2006; 71: 269–279
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Lüscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation. 1997; 96: 935–941
   Web of Science ®Google Scholar
• Hishikawa K, Oemar BS, Yang Z, Luscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kB in human coronary smooth muscle. Circ Res. 1997; 81: 797–803
   PubMed Web of Science ®Google Scholar
• Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol. 1997; 272: C421–C427
   PubMed Web of Science ®Google Scholar
• Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993; 75: 977–984
   PubMed Web of Science ®Google Scholar
• Predel H-G, Yang Z, Von Segesser L, Turina M, Buhler FR, Luscher TF. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet. 1992; 340: 878–879
   PubMed Web of Science ®Google Scholar
• Yang Z, Noll G, Lüscher TF. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Circulation. 1993; 88: 832–836
   PubMed Web of Science ®Google Scholar
• Zhang H, Schmeisser A, Garlichs Plotze K, Damme U, Mugge A, et al. Angiotensin II-induced superoxide generation in human vascular endothelial cells:role of membrane-bound NADH/NADPH–oxidases. Cardiovasc Res 1999; 44: 215–222
   PubMed Web of Science ®Google Scholar
• DeSilva PE, Husain A, Smeby RR, Khairallah PA. Measurement of immunoreactive angiotensin in rat tissues: some pitfalls in angiotensin II analysis. Anal Biochem 1988; 174: 80–87
   PubMed Web of Science ®Google Scholar
• Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells. Role of protein kinase C and reactive oxygen species. Circulation. 2003; 107: 1017–1023
   PubMed Web of Science ®Google Scholar
• Massey V. The microestimation of succinate and extinction coefficient of cytochrome c. Biochem Biophys Acta. 1959; 34: 255–257
   PubMed Web of Science ®Google Scholar
• Miller VM, Burnett JJ. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol. 1992; 248: H423–H437
   Google Scholar
• Pagano PJ, Clarck JK, Cifuentes-Pagano ME. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997; 94: 14483–14488
   PubMed Web of Science ®Google Scholar
• Lang D, Mosfer SI, Shakesby A, Donaldson F, Lewis MJ. Coronary microvascular endothelial cell redox state in left ventricular hypertrophy: The role of angiotensin II. Circ Res. 2000; 86: 463–469
   PubMed Web of Science ®Google Scholar
• Davies PF, Tripathi SC. Mechanical stress mechanism and the cell: An endothelial paradigm. Circ Res. 1993; 72: 239–245
   PubMed Web of Science ®Google Scholar
• Ballermann BJ, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int Suppl. 1998; 67: S100–S108
   PubMedGoogle Scholar
• Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension. 1995; 25: 449–452
   PubMed Web of Science ®Google Scholar
• Sumpio BE, Banes AJ. Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery. 1988; 104: 383–389
   PubMed Web of Science ®Google Scholar
• Wilson E, Mai Q, Sudhir K. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Biol Cell. 1993; 123: 741–747
   PubMed Web of Science ®Google Scholar
• Cheng GC, Libby P, Grodzinsky AJ, Lee RT. Induction of DNA synthesis by a single transient mechanical stimulus of human vascular smooth muscle cells. Circulation. 1996; 93: 99–105
   PubMed Web of Science ®Google Scholar
• Rubanyi GM, Freay AD, Kause K. Mechanoreception by the endothelium: Mediators and mechanisms of pressure- and flow-induced vascular responses. Blood Vessels. 1990; 27: 246–257
   PubMedGoogle Scholar
• Hemodynamic forces and vascular cell biology, BE Sumpio. RG Landes Co, Austin, Texas 1993; 1–119
   Google Scholar
• Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for the involvement of the renin-angiotensin system. Circulation. 1999; 99: 2027–2033
   PubMed Web of Science ®Google Scholar
• Khan BV, Sola S, Lauten WB, Natarajan R, Hooper WC, Menon RG. Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic sindrome. Diabetes Care. 2004; 27: 1712–1715
   PubMed Web of Science ®Google Scholar
• Lazaro A, Gallego-Delgado J, Justo P, Esteban V, Osende J, Mezzano S, et al. Long-term blood pressure control prevents oxidative renal injury. Antioxid Redox Signal. 2005; 7: 1285–1293
   PubMed Web of Science ®Google Scholar
• Landmesser U, Drexler H. Effect of angiotensin II type 1 receptor antagonism on endothelial function: Role of bradykinin and nitric oxide. Hypertens Suppl. 2006; 24: S39–S43
   PubMedGoogle Scholar
• Major TC, Overhiser RW, Taylor DJ, Jr, Panek RL. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasocostrictor activity in the isolated perfused mesenteric vasculature of hypertensive rats. J Pharm Exp Ther. 1993; 265: 187–193
   PubMed Web of Science ®Google Scholar
• Haefeli WE, Linder L, Lüscher TF. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans. Hypertension. 1997; 30: 912–917
   PubMed Web of Science ®Google Scholar
• Uehata A, Takase B, Nishioka T, Isojima K, Satomura K, Ohsura F, et al. Effect of quinapril versus nitrendipine on endothelial dysfunction in patients with systemic hypertension. Am J Cardiol. 2001; 87: 1414–1416
   PubMed Web of Science ®Google Scholar
• Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pupillo AL, Carere RG, et al. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation. 1996; 94: 258–265
   PubMed Web of Science ®Google Scholar
• Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annual Review of Pharmacology & Toxicology. 1996; 36: 281–306
   PubMed Web of Science ®Google Scholar
• Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of ACE-inhibitors in humans. Circulation. 1997; 95: 1115–1118
   PubMed Web of Science ®Google Scholar
• Benzing T, Fleming I, Blaukat A, Muller-Esterl W, Busse R. Angiotensin converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells. Circulation. 1999; 99: 2034–2040
   PubMed Web of Science ®Google Scholar
• Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998; 31: 349–355
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Matsubara H, Kurihara H, Murosawa S, Takai S, Miyazaki M. Angiotensin II type 2 overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999; 104: 925–935
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Krum H, Esler MD. Losartan increases bradykinin levels in hypertensive humans. Circulation. 2005; 111: 315–320
   PubMed Web of Science ®Google Scholar
• Sadoshima J. Novel AT1 receptor-independent functions of losartan. Circ Res. 2002; 90: 754–756
   PubMed Web of Science ®Google Scholar
• Dickstein K, Timmermans P, Segal R. Losartan: A selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure. Expert Opin Investig Drugs. 1998; 7: 1897–1914
   PubMedGoogle Scholar